首页 > 最新文献

Fetal Diagnosis and Therapy最新文献

英文 中文
A Clinical Outcomes Data Archive for a Comprehensive Fetal Diagnosis and Treatment Center. 一个综合性胎儿诊断和治疗中心的临床结果数据档案。
IF 1.6 3区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-08 DOI: 10.1159/000541877
Thomas A Reynolds, Matthew A Goldshore, Sabrina Flohr, Sierra Land, Leny Mathew, Juliana S Gebb, Edward R Oliver, Natalie E Rintoul, Anne M Ades, Elizabeth E Foglia, Catherine M Avitabile, Howard B Panitch, Gregory G Heuer, Lori J Howell, N Scott Adzick, Holly L Hedrick

Introduction: Data on near- and long-term clinical outcomes are critical for the care of all maternal-fetal patients presenting to a fetal center. This is especially important since physiologic and neurodevelopmental attributes do not manifest until later childhood when multilevel (e.g., individual, family, policy) factors have a direct influence on health outcomes. Electronic health records (EHRs) create opportunity for efficient data collection. However, documentation structures are not designed for acquisition of key attributes, and changes over time and between-clinician differences can affect resultant output. Therefore, EHR derived datasets have limited ability to accurately characterize the clinical presentation and care trajectory of patients with congenital anomalies. In addition, in most systems, the fetus lacks a digital identity and requires relinking fetal attributes documented in the maternal chart to those from the pediatric EHR. This conundrum amplifies in the setting of multiple gestation, returning maternal patients, and pregnancies with fetal demise. Moreover, current data capture systems result in incomplete abstraction of variables that may confound, mediate, or moderate critical associations. Our objective was to develop and implement a prospective data capture platform to transform EHR data into an analytic-grade database for multipurpose use.

Methods: A unified platform for longitudinal follow-up of maternal-child dyads cared for at our fetal center, named the Clinical Outcomes Data Archive (CODA), was constructed. CODA was designed using a data dictionary based on multidisciplinary and interprofessional expert input, a relational identity for each patient, fetus, and pregnancy, and a process by which EHR-sourced and chart-abstracted data are validated by a well-trained team. Descriptive analyses were performed for data acquired between July 2022 and July 2023, and a comparison of studies before and after implementation of CODA is presented.

Conclusion: 5,394,106 data points were validated for 7,662 patients across 12 conditions. 2% of data points were found to be unreliable or undocumented. 91% of data points were sourced from the EHR. Eighty-five percent of condition-specific variables required manual chart abstraction. The study conducted with CODA was able to contribute to 18 other studies. CODA successfully merges EHR-sourced and manually abstracted documentation for longitudinal study of the maternal-child dyad.

导言:有关近期和远期疗效的数据对所有到胎儿中心就诊的母胎患者的护理至关重要。这一点非常重要,因为生理和神经发育属性直到童年时期才会显现,而童年时期的多层次因素会影响健康结果。电子健康记录(EHR)的文档结构并不是为获取关键属性而设计的,随着时间的推移而发生的变化以及医生之间的差异都会影响结果的输出。因此,电子病历衍生数据集准确描述先天性畸形患者临床表现和护理轨迹的能力有限。此外,胎儿缺乏数字身份,需要将母体病历中记录的属性与儿科电子病历中的属性重新链接。这一难题在多胎妊娠、回流孕产妇和胎儿夭折的情况下会进一步扩大。目前的数据系统导致对变量的抽取不完整,而这些变量可能会混淆、调解或缓和关键关联。我们的目标是开发并实施一个前瞻性数据采集平台,将电子病历数据转化为分析级数据库,供多用途使用:方法:我们建立了一个统一的母婴二人组纵向随访平台,命名为临床结果数据档案(CODA)。CODA 的设计使用了基于多学科输入的数据字典,每个患者、胎儿和妊娠的关系标识,以及对电子病历来源和图表摘要数据进行验证的流程。对 2022 年 7 月至 2023 年 7 月期间获取的数据进行了描述性分析,并对实施 CODA 前后的研究进行了比较。发现 2% 的数据点不可靠或未记录。91%的数据点来自电子病历。85%的特定病症变量需要人工抽取病历。使用 CODA 进行的研究为 18 项研究做出了贡献。CODA 成功合并了电子病历来源和人工抽取的文档,用于母婴二元组的纵向研究。
{"title":"A Clinical Outcomes Data Archive for a Comprehensive Fetal Diagnosis and Treatment Center.","authors":"Thomas A Reynolds, Matthew A Goldshore, Sabrina Flohr, Sierra Land, Leny Mathew, Juliana S Gebb, Edward R Oliver, Natalie E Rintoul, Anne M Ades, Elizabeth E Foglia, Catherine M Avitabile, Howard B Panitch, Gregory G Heuer, Lori J Howell, N Scott Adzick, Holly L Hedrick","doi":"10.1159/000541877","DOIUrl":"10.1159/000541877","url":null,"abstract":"<p><strong>Introduction: </strong>Data on near- and long-term clinical outcomes are critical for the care of all maternal-fetal patients presenting to a fetal center. This is especially important since physiologic and neurodevelopmental attributes do not manifest until later childhood when multilevel (e.g., individual, family, policy) factors have a direct influence on health outcomes. Electronic health records (EHRs) create opportunity for efficient data collection. However, documentation structures are not designed for acquisition of key attributes, and changes over time and between-clinician differences can affect resultant output. Therefore, EHR derived datasets have limited ability to accurately characterize the clinical presentation and care trajectory of patients with congenital anomalies. In addition, in most systems, the fetus lacks a digital identity and requires relinking fetal attributes documented in the maternal chart to those from the pediatric EHR. This conundrum amplifies in the setting of multiple gestation, returning maternal patients, and pregnancies with fetal demise. Moreover, current data capture systems result in incomplete abstraction of variables that may confound, mediate, or moderate critical associations. Our objective was to develop and implement a prospective data capture platform to transform EHR data into an analytic-grade database for multipurpose use.</p><p><strong>Methods: </strong>A unified platform for longitudinal follow-up of maternal-child dyads cared for at our fetal center, named the Clinical Outcomes Data Archive (CODA), was constructed. CODA was designed using a data dictionary based on multidisciplinary and interprofessional expert input, a relational identity for each patient, fetus, and pregnancy, and a process by which EHR-sourced and chart-abstracted data are validated by a well-trained team. Descriptive analyses were performed for data acquired between July 2022 and July 2023, and a comparison of studies before and after implementation of CODA is presented.</p><p><strong>Conclusion: </strong>5,394,106 data points were validated for 7,662 patients across 12 conditions. 2% of data points were found to be unreliable or undocumented. 91% of data points were sourced from the EHR. Eighty-five percent of condition-specific variables required manual chart abstraction. The study conducted with CODA was able to contribute to 18 other studies. CODA successfully merges EHR-sourced and manually abstracted documentation for longitudinal study of the maternal-child dyad.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-9"},"PeriodicalIF":1.6,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142389216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Callosal injuries in cytomegalovirus fetopathy: a neurosonographic study. 巨细胞病毒胎儿病的胼胝体损伤:神经超声研究。
IF 1.6 3区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-04 DOI: 10.1159/000541794
Karina Krajden Haratz, Gustavo Malinger, Hadas Miremberg, Joseph Hartoov, Igal Wolman, Ariel Jaffa, Michael Busilov, Roee Birnbaum

Introduction - This study aimed to describe the rate and pattern of callosal injury in CMV fetopathy. Methods - This retrospective study included fetuses with confirmed CMV-PCR. Dedicated US including neurosonography was performed. Callosal Length below the 5th centile or morphological abnormalities were considered abnormal. Any additional abnormal findings were reported. Results - Seventy-two patients were included. In 76% infection occurred in the 1stT or periconceptional. In 34.7% a callosal anomaly was observed and it was never isolated. CNS abnormalities included: periventricular hyperechogenicity (PVHE) 55.5%, calcifications 52%, ventriculomegaly 33%, periventricular pseudocysts 31.4%, occipital cysts 22.2%, echogenic precaudate germinal matrix 30.5%, LSV 26.4%, sulcation abnormalities 22.2%, cerebellar findings 18% and HC below -2SD 18%. The most common association with CC insult was PVHE (56%) and calcifications (52%). Conclusion - Although not referred to as a classic brain structure affected by CMV infection, the CC was injured in one-third of our patients, including cases of late infection. The mechanism of disease and the prenatal patterns of callosal involvement in these cases appear to be different from the postnatal patterns and are not reversible. The presence of a callosal injury would imply a worse prognosis and a significant increment in the risk of neurodevelopmental impairment.

引言 - 本研究旨在描述 CMV 胎儿病中胼胝体损伤的发生率和模式。方法 - 这项回顾性研究包括确诊为 CMV-PCR 的胎儿。进行了包括神经超声在内的专用超声检查。胼胝体长度低于第 5 百分位数或形态异常被视为异常。任何其他异常结果均需报告。结果 - 共纳入 72 例患者。76%的患者感染发生在第1胎或围产期。34.7%的患者出现胼胝体异常,但从未被分离出来。中枢神经系统异常包括:脑室周围高回声(PVHE)55.5%、钙化52%、脑室肿大33%、脑室周围假性囊肿31.4%、枕囊肿22.2%、回声前包膜生发基质30.5%、LSV26.4%、沟纹异常22.2%、小脑发现18%和HC低于-2SD18%。与CC损伤最常见的关联是PVHE(56%)和钙化(52%)。结论 - 尽管CC并不是受CMV感染影响的典型脑结构,但三分之一的患者(包括晚期感染病例)的CC受到了损伤。这些病例的发病机制和胼胝体受累的产前模式似乎与产后模式不同,且不可逆转。胼胝体损伤的存在意味着预后较差,神经发育障碍的风险显著增加。
{"title":"Callosal injuries in cytomegalovirus fetopathy: a neurosonographic study.","authors":"Karina Krajden Haratz, Gustavo Malinger, Hadas Miremberg, Joseph Hartoov, Igal Wolman, Ariel Jaffa, Michael Busilov, Roee Birnbaum","doi":"10.1159/000541794","DOIUrl":"https://doi.org/10.1159/000541794","url":null,"abstract":"<p><p>Introduction - This study aimed to describe the rate and pattern of callosal injury in CMV fetopathy. Methods - This retrospective study included fetuses with confirmed CMV-PCR. Dedicated US including neurosonography was performed. Callosal Length below the 5th centile or morphological abnormalities were considered abnormal. Any additional abnormal findings were reported. Results - Seventy-two patients were included. In 76% infection occurred in the 1stT or periconceptional. In 34.7% a callosal anomaly was observed and it was never isolated. CNS abnormalities included: periventricular hyperechogenicity (PVHE) 55.5%, calcifications 52%, ventriculomegaly 33%, periventricular pseudocysts 31.4%, occipital cysts 22.2%, echogenic precaudate germinal matrix 30.5%, LSV 26.4%, sulcation abnormalities 22.2%, cerebellar findings 18% and HC below -2SD 18%. The most common association with CC insult was PVHE (56%) and calcifications (52%). Conclusion - Although not referred to as a classic brain structure affected by CMV infection, the CC was injured in one-third of our patients, including cases of late infection. The mechanism of disease and the prenatal patterns of callosal involvement in these cases appear to be different from the postnatal patterns and are not reversible. The presence of a callosal injury would imply a worse prognosis and a significant increment in the risk of neurodevelopmental impairment.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-17"},"PeriodicalIF":1.6,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142380402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum. 勘误。
IF 1.6 3区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-03 DOI: 10.1159/000541608
{"title":"Erratum.","authors":"","doi":"10.1159/000541608","DOIUrl":"https://doi.org/10.1159/000541608","url":null,"abstract":"","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1"},"PeriodicalIF":1.6,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142371400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Double Outlet Left Ventricle with Intact Ventricular Septum: A Rare Prenatally Diagnosed Case Report. 双出口左心室伴完整的室间隔:一个罕见的产前诊断病例报告。
IF 1.6 3区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-26 DOI: 10.1159/000541164
Jyoti Gur, Michael P Collins, Frank Smith, Lauren Tague

Introduction: Double outlet left ventricle (DOLV) is a rare congenital heart anomaly, and cases of DOLV with an intact ventricular septum are uncommon. To date, only four such cases have been reported in the medical literature.

Case presentation: This report presents a case of prenatally diagnosed DOLV. A fetal echocardiogram at 21 weeks of gestation demonstrated both great arteries, aorta and pulmonary artery, arising from the left ventricle with severely dysplastic tricuspid valve and severe hypoplasia of the right ventricle. Subsequent echocardiograms demonstrated no ventricular septal defect. The patient required balloon atrial septostomy in the first week of life, underwent pulmonary artery banding at 5 weeks of life, and is currently status post-bidirectional Glenn, and is awaiting final Fontan palliation.

Conclusion: Prenatal diagnosis aided in predicting and guiding postnatal management.

导言双出口左心室(DOLV)是一种罕见的先天性心脏畸形,心室间隔完整的双出口左心室病例并不多见。迄今为止,医学文献中仅报道过四例此类病例:本报告介绍了一例产前确诊的 DOLV 病例。妊娠 21 周时的胎儿超声心动图显示,主动脉和肺动脉均来自左心室,三尖瓣严重发育不良,右心室严重发育不良。随后的超声心动图显示没有室间隔缺损。患者在出生后第一周需要进行球囊心房隔成形术,在出生后5周接受了肺动脉束缚术,目前处于双向格伦术后状态,正在等待最终的丰坦姑息治疗:结论:产前诊断有助于预测和指导产后管理。
{"title":"Double Outlet Left Ventricle with Intact Ventricular Septum: A Rare Prenatally Diagnosed Case Report.","authors":"Jyoti Gur, Michael P Collins, Frank Smith, Lauren Tague","doi":"10.1159/000541164","DOIUrl":"https://doi.org/10.1159/000541164","url":null,"abstract":"<p><strong>Introduction: </strong>Double outlet left ventricle (DOLV) is a rare congenital heart anomaly, and cases of DOLV with an intact ventricular septum are uncommon. To date, only four such cases have been reported in the medical literature.</p><p><strong>Case presentation: </strong>This report presents a case of prenatally diagnosed DOLV. A fetal echocardiogram at 21 weeks of gestation demonstrated both great arteries, aorta and pulmonary artery, arising from the left ventricle with severely dysplastic tricuspid valve and severe hypoplasia of the right ventricle. Subsequent echocardiograms demonstrated no ventricular septal defect. The patient required balloon atrial septostomy in the first week of life, underwent pulmonary artery banding at 5 weeks of life, and is currently status post-bidirectional Glenn, and is awaiting final Fontan palliation.</p><p><strong>Conclusion: </strong>Prenatal diagnosis aided in predicting and guiding postnatal management.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-5"},"PeriodicalIF":1.6,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Chorionicity in Placenta-Related Disorders. 绒毛膜性在胎盘相关疾病中的作用。
IF 1.6 3区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-23 DOI: 10.1159/000541457
Yana Brudner, Arwa Issa, Hila Sharabi, Livna Shafat, Boaz Weisz, Alon Shrim

Introduction: Twin pregnancy is associated with higher rates of maternal morbidities including gestational diabetes and hypertension. Dichorionic twins are believed to have greater placental mass. Our objective was to study the incidence of two placenta-related disorders: gestational diabetes and hypertension, in dichorionic versus monochorionic twin pregnancies.

Methods: Patients' data of all consecutive twin pregnancies over a period of 12 years were collected from medical records. Data on chorionicity were retrieved from 1st trimester ultrasound reports. Maternal complications including gestational hypertension and diabetes were collected, and incidence was compared between dichorionic and monochorionic twin pregnancies. Records lacking chorionicity data and cases with pregestational diabetes were excluded.

Results: A total of 960 twin pregnancies, 121 monochorionic and 839 dichorionic, were included. Average maternal age did not differ significantly between the groups. The median gestational age at delivery was 36.0 weeks in monochorionic and 36.7 in dichorionic twins. Primiparity (40.4% vs. 23.1%, p < 0.001) and the rate of infertility treatments (51.5% vs. 7.4%, p < 0.001) were both more common in the dichorionic group. The incidence of gestational hypertension disorders was 14% in monochorionic versus 11% in dichorionic twins (p = 0.36). Gestational diabetes was more common in dichorionic compared to monochorionic twins (9.4% and 2.5%, respectively); however, logistic multivariate analysis showed that gestational diabetes was highly correlated with maternal age (p < 0.001) and infertility treatments (p < 0.001) but not with chorionicity (p = 0.136).

Conclusion: Our results may imply that greater placental mass does not increase the risk for gestational hypertension and diabetes. This might support the role of additional multiple maternal factors associated with these complications.

导言:双胎妊娠与较高的产妇发病率有关,包括妊娠糖尿病和高血压。二绒毛膜双胎被认为胎盘质量更大。我们的目的是研究二绒毛膜双胎妊娠与单绒毛膜双胎妊娠两种胎盘相关疾病:妊娠糖尿病和高血压的发病率:方法:从医疗记录中收集 12 年间所有连续双胎妊娠患者的数据。绒毛膜性的数据来自怀孕头三个月的超声波报告。收集了包括妊娠高血压和糖尿病在内的产妇并发症,并对二绒毛膜双胎和单绒毛膜双胎的发生率进行了比较。缺乏绒毛膜性数据的记录和妊娠前糖尿病病例被排除在外:结果:共纳入了 960 例双胎妊娠,其中 121 例为单绒毛膜双胎,839 例为二绒毛膜双胎。两组孕妇的平均年龄无明显差异。单绒毛膜双胎和二绒毛膜双胎的中位胎龄分别为 36.0 周和 36.7 周。二绒毛膜双胎组的初产率(40.4% 对 23.1%,p<0.001)和不孕症治疗率(51.5% 对 7.4%,p<0.001)均较高。单绒毛膜双胎的妊娠高血压发病率为14%,而二绒毛膜双胎为11%(P=0.36)。妊娠糖尿病在二绒毛膜双胎中比单绒毛膜双胎更常见(分别为9.4%和2.5%),但逻辑回归分析显示,妊娠糖尿病与产妇年龄(p<0.001)和不孕治疗(p<0.001)高度相关,但与绒毛膜性无关(p=0.136):我们的结果可能意味着,胎盘质量越大并不会增加妊娠高血压和糖尿病的风险。结论:我们的结果可能意味着,胎盘质量越大并不会增加妊娠高血压和糖尿病的风险,这可能支持了与这些并发症相关的其他多种母体因素的作用。
{"title":"The Role of Chorionicity in Placenta-Related Disorders.","authors":"Yana Brudner, Arwa Issa, Hila Sharabi, Livna Shafat, Boaz Weisz, Alon Shrim","doi":"10.1159/000541457","DOIUrl":"10.1159/000541457","url":null,"abstract":"<p><strong>Introduction: </strong>Twin pregnancy is associated with higher rates of maternal morbidities including gestational diabetes and hypertension. Dichorionic twins are believed to have greater placental mass. Our objective was to study the incidence of two placenta-related disorders: gestational diabetes and hypertension, in dichorionic versus monochorionic twin pregnancies.</p><p><strong>Methods: </strong>Patients' data of all consecutive twin pregnancies over a period of 12 years were collected from medical records. Data on chorionicity were retrieved from 1st trimester ultrasound reports. Maternal complications including gestational hypertension and diabetes were collected, and incidence was compared between dichorionic and monochorionic twin pregnancies. Records lacking chorionicity data and cases with pregestational diabetes were excluded.</p><p><strong>Results: </strong>A total of 960 twin pregnancies, 121 monochorionic and 839 dichorionic, were included. Average maternal age did not differ significantly between the groups. The median gestational age at delivery was 36.0 weeks in monochorionic and 36.7 in dichorionic twins. Primiparity (40.4% vs. 23.1%, p &lt; 0.001) and the rate of infertility treatments (51.5% vs. 7.4%, p &lt; 0.001) were both more common in the dichorionic group. The incidence of gestational hypertension disorders was 14% in monochorionic versus 11% in dichorionic twins (p = 0.36). Gestational diabetes was more common in dichorionic compared to monochorionic twins (9.4% and 2.5%, respectively); however, logistic multivariate analysis showed that gestational diabetes was highly correlated with maternal age (p &lt; 0.001) and infertility treatments (p &lt; 0.001) but not with chorionicity (p = 0.136).</p><p><strong>Conclusion: </strong>Our results may imply that greater placental mass does not increase the risk for gestational hypertension and diabetes. This might support the role of additional multiple maternal factors associated with these complications.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-6"},"PeriodicalIF":1.6,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142307416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased Intrauterine Transfusion Blood Volume Needed to Correct Fetal Anemia due to Placental Chorioangioma. 为纠正胎盘绒毛膜血管瘤导致的胎儿贫血,需要增加宫内输血量。
IF 1.6 3区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-20 DOI: 10.1159/000541560
Catherine Hamzeh, Jessica Green, Grace Hamadeh, Lisa M Korst, Ramen H Chmait

Introduction: To compare the blood volume transfused for fetal anemia in cases of placental chorioangioma versus red blood cell (RBC) alloimmunization in patients matched for gestational age (GA) and hydrops.

Methods: Study patients had intrauterine transfusions and were obtained from 3 sources: group (1) placental chorioangioma patients treated at our center (2016-2023); group (2) placental chorioangioma patients reported in the medical literature; and group (3) RBC alloimmunization patients treated for fetal anemia at our center (2016-2023) matched (2:1) to patients in groups 1 and 2 by GA at procedure and presence of hydrops. The expected volume (cc) of transfusion was calculated for all patients based on a formula commonly used for fetal anemia in cases of RBC alloimmunization that includes the GA at procedure, pre-transfusion hemoglobin, donor hemoglobin, and target hemoglobin. The ratio of the volume actually transfused to the expected volume was calculated for each group and for groups 1 and 2 combined; comparisons were made using nonparametric testing.

Results: By group, the patients studied included: (1) 7 treated chorioangioma patients, (2) 8 chorioangioma patients described in the literature, and (3) 30 matched RBC alloimmunization patients. The median (range) GA at procedure for groups 1, 2, and 3 was 29.6 (22.7-32.7), 27.0 (24.0-30.0), 28.4 (22.7-34.3) weeks. The median pre-procedure hemoglobin for each group was 8.5 (5.8-12.5), 6.7 (5.6-12.0), and 5.3 (2.2-10.7) g/dL, and the median post-procedure hemoglobin for each group was 12.9 (11.5-14.0), 12.7 (9.6-14.7), and 13.6 (8.0-15.7) g/dL. The median (range) ratio of the actual to the expected volume transfused for each group was 2.50 (1.79-8.33), 1.64 (1.11-3.85), and 1.10 (0.69-1.86) (p < 0.001). When groups 1 and 2 were combined, the median ratio was 1.89 (1.11-8.33), which remained statistically significant when compared to group 3 (p < 0.001).

Conclusion: Intrauterine transfusion for fetal anemia in cases of large placental chorioangiomas appeared to require nearly twice the blood volume that was normally anticipated for cases of RBC alloimmunization, although the actual amount transfused varied widely.

简介:目的目的:比较胎盘绒毛膜血管瘤与红细胞(RBC)同种免疫患者因胎龄(GA)和肾积水匹配而导致胎儿贫血的输血量:研究患者均有宫内输血,并从 3 个来源获得红细胞:第一组:在本中心接受治疗的胎盘绒毛膜血管瘤患者(2016-2023年);第二组:医学文献中报道的胎盘绒毛膜血管瘤患者;第三组:在本中心因胎儿贫血接受治疗的RBC同种免疫患者(2016-2023年),与第一组和第二组患者的匹配比例(2:1)为手术时的胎龄(GA)和是否存在肾积水。所有患者的预期输血量(cc)都是根据红细胞异体免疫病例中胎儿贫血的常用公式计算得出的,该公式包括手术时的GA、输血前血红蛋白、供体血红蛋白和目标血红蛋白。计算各组以及第一组和第二组的实际输血量与预期输血量之比;使用非参数检验进行比较:按组别划分,研究的患者包括(1)7名接受过治疗的绒毛膜血管瘤患者,(2)8名文献中描述的绒毛膜血管瘤患者,(3)30名匹配的RBC异体免疫患者。第 1 组、第 2 组和第 3 组患者手术时的年龄中位数(范围)分别为 29.6(22.7-32.7)周、27.0(24.0-30.0)周和 28.4(22.7-34.3)周。各组术前血红蛋白中位数分别为 8.5 (5.8-12.5)、6.7 (5.6-12.0) 和 5.3 (2.2-10.7) g/dl,各组术后血红蛋白中位数分别为 12.9 (11.5-14.0)、12.7 (9.6-14.7) 和 13.6 (8.0-15.7) g/dl。各组实际输血量与预期输血量之比的中位数(范围)分别为 2.50(1.79-8.33)、1.64(1.11-3.85)和 1.10(0.69-1.86)(P<.001)。将第 1 组和第 2 组合并后,中位比值为 1.89(1.11-8.33),与第 3 组相比仍具有统计学意义(P< .001):结论:胎盘巨大绒毛膜血管瘤病例中,宫内输血治疗胎儿贫血所需的血量似乎是通常预计的红细胞异体免疫病例血量的近两倍,尽管实际输血量差异很大。
{"title":"Increased Intrauterine Transfusion Blood Volume Needed to Correct Fetal Anemia due to Placental Chorioangioma.","authors":"Catherine Hamzeh, Jessica Green, Grace Hamadeh, Lisa M Korst, Ramen H Chmait","doi":"10.1159/000541560","DOIUrl":"10.1159/000541560","url":null,"abstract":"<p><strong>Introduction: </strong>To compare the blood volume transfused for fetal anemia in cases of placental chorioangioma versus red blood cell (RBC) alloimmunization in patients matched for gestational age (GA) and hydrops.</p><p><strong>Methods: </strong>Study patients had intrauterine transfusions and were obtained from 3 sources: group (1) placental chorioangioma patients treated at our center (2016-2023); group (2) placental chorioangioma patients reported in the medical literature; and group (3) RBC alloimmunization patients treated for fetal anemia at our center (2016-2023) matched (2:1) to patients in groups 1 and 2 by GA at procedure and presence of hydrops. The expected volume (cc) of transfusion was calculated for all patients based on a formula commonly used for fetal anemia in cases of RBC alloimmunization that includes the GA at procedure, pre-transfusion hemoglobin, donor hemoglobin, and target hemoglobin. The ratio of the volume actually transfused to the expected volume was calculated for each group and for groups 1 and 2 combined; comparisons were made using nonparametric testing.</p><p><strong>Results: </strong>By group, the patients studied included: (1) 7 treated chorioangioma patients, (2) 8 chorioangioma patients described in the literature, and (3) 30 matched RBC alloimmunization patients. The median (range) GA at procedure for groups 1, 2, and 3 was 29.6 (22.7-32.7), 27.0 (24.0-30.0), 28.4 (22.7-34.3) weeks. The median pre-procedure hemoglobin for each group was 8.5 (5.8-12.5), 6.7 (5.6-12.0), and 5.3 (2.2-10.7) g/dL, and the median post-procedure hemoglobin for each group was 12.9 (11.5-14.0), 12.7 (9.6-14.7), and 13.6 (8.0-15.7) g/dL. The median (range) ratio of the actual to the expected volume transfused for each group was 2.50 (1.79-8.33), 1.64 (1.11-3.85), and 1.10 (0.69-1.86) (p &lt; 0.001). When groups 1 and 2 were combined, the median ratio was 1.89 (1.11-8.33), which remained statistically significant when compared to group 3 (p &lt; 0.001).</p><p><strong>Conclusion: </strong>Intrauterine transfusion for fetal anemia in cases of large placental chorioangiomas appeared to require nearly twice the blood volume that was normally anticipated for cases of RBC alloimmunization, although the actual amount transfused varied widely.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-7"},"PeriodicalIF":1.6,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142282695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prenatal Diagnosis of Anomalous Origin of the Left Pulmonary Artery in Fetus with a Right-Sided Aortic Arch - Case Report and Review of the Literature. 右侧主动脉弓胎儿左肺动脉起源异常的产前诊断 - 病例报告和文献综述。
IF 2.2 3区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-17 DOI: 10.1159/000541432
Laura Szlang,Rabih Chaoui,Bernd Opgen-Rhein,Mi-Young Cho,Wolfgang Henrich
Introduction Anomalous origin of the left pulmonary artery (AOLPA) is an exceptionally rare congenital malformation, requiring particular care to be detected during fetal echocardiography. Case presentation A 30-year-old woman, gravida 1, para 0, was referred for a mid-trimester anomaly scan. The three-vessel tracheal view in fetal echocardiographic examination led to the prenatal detection of an anomalous origin of the left pulmonary artery in the presence of a right-sided aortic arch. Additionally, a bilateral arterial duct and the ductal origin of the left pulmonary artery (LPA) were detected postnatally. Prenatal diagnosis enabled the scheduling of the delivery in a tertiary perinatal center, immediate postnatal treatment with prostaglandin E1 to avoid obstruction of the isolated LPA as well as surgical repair of the anomaly. Conclusion The rareness of the disease led to only sporadically published cases of prenatal diagnosis of AOLPA. However, early detection makes prenatal diagnosis crucial regarding the infants' outcome. This case report underlines the importance of a meticulous examination of the bifurcation of the pulmonary trunk during fetal echocardiography.
导言:左肺动脉起源异常(AOLPA)是一种非常罕见的先天性畸形,在胎儿超声心动图检查时需要特别小心。病例介绍 一位 30 岁的妇女,孕酮 1,para 0,被转诊进行孕中期异常扫描。胎儿超声心动图检查中的三血管气管切面导致产前发现左肺动脉起源异常,同时存在右侧主动脉弓。此外,产后还发现了双侧动脉导管和左肺动脉(LPA)的导管起源。通过产前诊断,患者被安排在一家三级围产中心分娩,产后立即使用前列腺素E1治疗,以避免孤立的左肺动脉阻塞,并通过手术修复了畸形。结论 由于这种疾病的罕见性,产前诊断 AOLPA 的病例仅有零星发表。然而,早期发现使得产前诊断对婴儿的预后至关重要。本病例报告强调了在胎儿超声心动图检查中仔细检查肺动脉干分叉的重要性。
{"title":"Prenatal Diagnosis of Anomalous Origin of the Left Pulmonary Artery in Fetus with a Right-Sided Aortic Arch - Case Report and Review of the Literature.","authors":"Laura Szlang,Rabih Chaoui,Bernd Opgen-Rhein,Mi-Young Cho,Wolfgang Henrich","doi":"10.1159/000541432","DOIUrl":"https://doi.org/10.1159/000541432","url":null,"abstract":"Introduction Anomalous origin of the left pulmonary artery (AOLPA) is an exceptionally rare congenital malformation, requiring particular care to be detected during fetal echocardiography. Case presentation A 30-year-old woman, gravida 1, para 0, was referred for a mid-trimester anomaly scan. The three-vessel tracheal view in fetal echocardiographic examination led to the prenatal detection of an anomalous origin of the left pulmonary artery in the presence of a right-sided aortic arch. Additionally, a bilateral arterial duct and the ductal origin of the left pulmonary artery (LPA) were detected postnatally. Prenatal diagnosis enabled the scheduling of the delivery in a tertiary perinatal center, immediate postnatal treatment with prostaglandin E1 to avoid obstruction of the isolated LPA as well as surgical repair of the anomaly. Conclusion The rareness of the disease led to only sporadically published cases of prenatal diagnosis of AOLPA. However, early detection makes prenatal diagnosis crucial regarding the infants' outcome. This case report underlines the importance of a meticulous examination of the bifurcation of the pulmonary trunk during fetal echocardiography.","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":"208 1","pages":"1-19"},"PeriodicalIF":2.2,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142262424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transamniotic Fetal Immunotherapy (TRAFIT) with Secretory IgA: A Potential Novel Ancillary Strategy for the Prevention of Necrotizing Enterocolitis. 使用分泌型 IgA 的经羊膜胎儿免疫疗法 (TRAFIT):预防坏死性小肠结肠炎的潜在新型辅助策略。
IF 2.2 3区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-12 DOI: 10.1159/000541434
Ashlyn E Whitlock,Kamila Moskowitzova,Ina Kycia,Jeffrey Nelson,David Zurakowski,Dario O Fauza
INTRODUCTIONSecretory immunoglobulin-A (SIgA), which is not produced perinatally, binds bacteria enhancing mucosal immunity. Higher levels of intestinal bacteria bound by SIgA are protective against necrotizing enterocolitis. Transamniotic fetal immunotherapy (TRAFIT) has previously been used to deliver SIgA to the fetal digestive tract, however with unclear functional impact. We sought to determine whether SIgA administered via TRAFIT could functionally bind intestinal bacteria postnatally.METHODSFetuses (n=38) from four dams underwent intra-amniotic injections of human SIgA on gestational-day 19 (E19; term=E22-E23). After spontaneous delivery, pups were survived for 1-2 days postnatally before intestinal contents were procured and submitted to flow cytometry. Specimens were stained for bacteria (Syto-GFP) and human-SIgA (PE) to prevent cross-reactivity with maternal rat SIgA.RESULTSOverall survival was 94.7% (36/38). SIgA-bacterial complexes were identified in all samples at all time points showing significantly higher positive PE events than unstained controls (p=0.03-0.05). The proportion of bacteria bound by IgA decreased daily, from 45.6% to 29.9% bound at 4 to 6 days post-TRAFIT, respectively (overall p=0.05).CONCLUSIONSTransamniotic fetal immunotherapy with secretory-IgA leads to functionally IgA-bound bacteria into the postnatal period and may be a novel strategy for enhancing early mucosal immunity, potentially protecting the neonate against necrotizing enterocolitis.
简介分泌性免疫球蛋白-A(SIgA)不会在围产期产生,它能与细菌结合,增强粘膜免疫能力。SIgA 结合的肠道细菌水平越高,对坏死性小肠结肠炎越有保护作用。经羊膜胎儿免疫疗法(TRAFIT)曾被用于向胎儿消化道输送 SIgA,但其功能影响尚不明确。我们试图确定通过 TRAFIT 给药的 SIgA 是否能在出生后与肠道细菌发生功能性结合。方法四个母体的胎儿(38 个)在妊娠第 19 天(E19;足月=E22-E23)接受了人类 SIgA 的羊膜腔内注射。自然分娩后,幼崽在产后存活 1-2 天,然后采集肠道内容物并进行流式细胞术检测。标本经细菌(Syto-GFP)和人SIgA(PE)染色,以防止与母体大鼠SIgA发生交叉反应。结果总存活率为94.7%(36/38)。在所有时间点的所有样本中都发现了 SIgA-细菌复合物,显示 PE 阳性事件明显高于未染色对照组(p=0.03-0.05)。结论用分泌型 IgA 进行经羊膜胎儿免疫治疗可使 IgA 结合细菌进入出生后阶段,这可能是增强早期粘膜免疫的一种新策略,有可能保护新生儿免受坏死性小肠结肠炎的侵害。
{"title":"Transamniotic Fetal Immunotherapy (TRAFIT) with Secretory IgA: A Potential Novel Ancillary Strategy for the Prevention of Necrotizing Enterocolitis.","authors":"Ashlyn E Whitlock,Kamila Moskowitzova,Ina Kycia,Jeffrey Nelson,David Zurakowski,Dario O Fauza","doi":"10.1159/000541434","DOIUrl":"https://doi.org/10.1159/000541434","url":null,"abstract":"INTRODUCTIONSecretory immunoglobulin-A (SIgA), which is not produced perinatally, binds bacteria enhancing mucosal immunity. Higher levels of intestinal bacteria bound by SIgA are protective against necrotizing enterocolitis. Transamniotic fetal immunotherapy (TRAFIT) has previously been used to deliver SIgA to the fetal digestive tract, however with unclear functional impact. We sought to determine whether SIgA administered via TRAFIT could functionally bind intestinal bacteria postnatally.METHODSFetuses (n=38) from four dams underwent intra-amniotic injections of human SIgA on gestational-day 19 (E19; term=E22-E23). After spontaneous delivery, pups were survived for 1-2 days postnatally before intestinal contents were procured and submitted to flow cytometry. Specimens were stained for bacteria (Syto-GFP) and human-SIgA (PE) to prevent cross-reactivity with maternal rat SIgA.RESULTSOverall survival was 94.7% (36/38). SIgA-bacterial complexes were identified in all samples at all time points showing significantly higher positive PE events than unstained controls (p=0.03-0.05). The proportion of bacteria bound by IgA decreased daily, from 45.6% to 29.9% bound at 4 to 6 days post-TRAFIT, respectively (overall p=0.05).CONCLUSIONSTransamniotic fetal immunotherapy with secretory-IgA leads to functionally IgA-bound bacteria into the postnatal period and may be a novel strategy for enhancing early mucosal immunity, potentially protecting the neonate against necrotizing enterocolitis.","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":"30 1","pages":"1-17"},"PeriodicalIF":2.2,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142262425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transamniotic Delivery of Surfactant Protein B mRNA in a Healthy Model. 在健康模型中经羊膜输送表面活性蛋白 B mRNA。
IF 2.2 3区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-12 DOI: 10.1159/000541429
Kamila Moskowitzova,Abbie E Naus,Tanya T Dang,David Zurakowski,Dario O Fauza
INTRODUCTIONWe sought to determine whether exogenous surfactant protein B (SPB) mRNA could be incorporated and translated by the fetal lung after simple transamniotic administration.METHODSFetuses (n=149) of twelve time-dated dams underwent intra-amniotic injections of either human SPB (hSPB) mRNA encapsulated into lipopolyplex (mRNA, n=99), or of lipopolyplex without mRNA (control; n=50) on gestational day 17 (E17, term=E21-22). Lungs were screened for hSPB by ELISA daily until term. Phosphatidylcholine (a surrogate for surfactant production) was measured in the amniotic fluid by fluorometric assay. Statistical analysis included nonparametric Wilcoxon rank sum test.RESULTSSignificantly improved survival in the mRNA group compared to controls was observed at E18 (100% vs. 85.7%) and E20 (100% vs. 83.3%) (both p<0.001). When controlled by mRNA-free injections, hSPB protein was detected in the mRNA group's lungs at E18, 19, and term (p=0.002 to <0.001). Amniotic fluid phosphatidylcholine levels were increased compared to control at term [285.9 (251.1, 363.9)μM vs. 263.1 (222.8, 309.1)μM], however this did not reach significance (p=0.33).CONCLUSIONSEncapsulated exogenous SPB mRNA can be incorporated and translated by fetal lung cells following intra-amniotic injection in a healthy rat model. Transamniotic mRNA delivery could become a novel strategy for perinatal surfactant protein replacement.
引言我们试图确定外源性表面活性蛋白B(SPB)mRNA是否能通过简单的羊膜腔注射被胎儿肺部吸收和翻译。方法12个不同时间段的母体的胎儿(n=149)在妊娠第17天(E17,足月=E21-22)接受羊膜腔内注射包裹在脂质多聚物中的人SPB(hSPB)mRNA(mRNA,n=99)或不含mRNA的脂质多聚物(对照;n=50)。每天用 ELISA 方法筛查肺部的 hSPB,直至足月。通过荧光测定法测量羊水中的磷脂酰胆碱(表面活性物质生成的替代物)。结果与对照组相比,mRNA 组在 E18(100% 对 85.7%)和 E20(100% 对 83.3%)时的存活率显著提高(均为 p<0.001)。如果用不含 mRNA 的注射进行对照,在 E18、19 和足月时,mRNA 组的肺中可检测到 hSPB 蛋白(p=0.002 至 <0.001)。与对照组相比,羊水磷脂酰胆碱水平在足月时有所增加[285.9 (251.1, 363.9)μM vs. 263.1 (222.8, 309.1)μM],但这并不显著(p=0.33)。经羊膜递送 mRNA 可成为围产期表面活性蛋白替代的一种新策略。
{"title":"Transamniotic Delivery of Surfactant Protein B mRNA in a Healthy Model.","authors":"Kamila Moskowitzova,Abbie E Naus,Tanya T Dang,David Zurakowski,Dario O Fauza","doi":"10.1159/000541429","DOIUrl":"https://doi.org/10.1159/000541429","url":null,"abstract":"INTRODUCTIONWe sought to determine whether exogenous surfactant protein B (SPB) mRNA could be incorporated and translated by the fetal lung after simple transamniotic administration.METHODSFetuses (n=149) of twelve time-dated dams underwent intra-amniotic injections of either human SPB (hSPB) mRNA encapsulated into lipopolyplex (mRNA, n=99), or of lipopolyplex without mRNA (control; n=50) on gestational day 17 (E17, term=E21-22). Lungs were screened for hSPB by ELISA daily until term. Phosphatidylcholine (a surrogate for surfactant production) was measured in the amniotic fluid by fluorometric assay. Statistical analysis included nonparametric Wilcoxon rank sum test.RESULTSSignificantly improved survival in the mRNA group compared to controls was observed at E18 (100% vs. 85.7%) and E20 (100% vs. 83.3%) (both p&lt;0.001). When controlled by mRNA-free injections, hSPB protein was detected in the mRNA group's lungs at E18, 19, and term (p=0.002 to &lt;0.001). Amniotic fluid phosphatidylcholine levels were increased compared to control at term [285.9 (251.1, 363.9)μM vs. 263.1 (222.8, 309.1)μM], however this did not reach significance (p=0.33).CONCLUSIONSEncapsulated exogenous SPB mRNA can be incorporated and translated by fetal lung cells following intra-amniotic injection in a healthy rat model. Transamniotic mRNA delivery could become a novel strategy for perinatal surfactant protein replacement.","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":"6 1","pages":"1-14"},"PeriodicalIF":2.2,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142262426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neonatal Outcomes of Multiple Congenital Thoracic Lesions. 多发性先天性胸廓病变的新生儿结局。
IF 1.6 3区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-07 DOI: 10.1159/000541319
Anthony di Natale, Sabrina Flohr, Leny Mathew, Cara Katterman, Colby Gallagher, Thomas A Reynolds, Juliana S Gebb, Howard B Panitch, Edward R Oliver, Natalie E Rintoul, William H Peranteau, Alan W Flake, N Scott Adzick, Holly L Hedrick

Introduction: Congenital pulmonary airway malformations (CPAM), intra- and extralobar bronchopulmonary sequestrations (iBPS/eBPS), CPAM-BPS hybrid lesions (HL), congenital lobar emphysema (CLE), bronchial atresia (BA), and foregut duplication cysts (FDC), collectively referred to as congenital thoracic lesions (CTL), are mostly solitary. Patients with multiple CTL are rare, and reports on such cases are scarce. To address this dearth, we analyzed a large multifocal CTL patient cohort.

Methods: Retrospective chart review of patients born between September 1, 2013, and March 31, 2023, who underwent surgery for a CTL at our tertiary center. Patients with radiological and surgical diagnosis of multifocal CTL, defined as ≥2 CTL present in more than one lobe were included to record pre-, peri-, and postnatal patient characteristics.

Results: Among 701 CTL patients, 74 (10.5%) had multiple CTL. CTL multifocality was prenatally recognized correctly in 8 (12.9%) patients. Most multiple CTL were right-sided, unilateral multilobar lesions (n = 33, 44%). Bilateral CTL were found in 9 (12.1%) patients. CPAM-CPAM lesions were the most prevalent CTL types (n = 36, 49%). Genetic syndromes were confirmed in 3 (4%) and additional congenital anomalies in 9 (12.9%) patients, 5 of those had multiple congenital anomalies. Of 49 (65%) patients with multilobar CTL, 25 (51%) underwent bilobectomy and 24 (49%) lung-sparing surgery. Length of stay was similar. Mortality was 5.4%.

Conclusion: We report on the largest patient cohort with multiple CTL to date. Multiple CTL occurred in 1/10 patients with CTL, and only 12.9% were recognized prenatally. Lung-sparing surgery can be considered. Multiple additional congenital anomalies and genetic syndromes may be more common and genetic testing should be considered. Overall, outcomes in this patient population are favorable.

导言:先天性肺气道畸形 (CPAM)、小叶内和小叶外支气管肺固着 (iBPS/eBPS)、CPAM-BPS 混合病变 (HL)、先天性肺叶气肿 (CLE)、支气管闭锁 (BA) 和前肠重复囊肿 (FDC),统称为先天性胸部病变 (CTL),大多为单发。多发性 CTL 患者很少见,有关此类病例的报道也很少。为了解决这一问题,我们对一个大型多灶性 CTL 患者群进行了分析:方法:对2013年1月1日至2023年3月31日期间出生、在我们的三级医疗中心接受过CTL手术的患者进行回顾性病历审查。纳入放射学和手术诊断为多灶 CTL(定义为一个以上肺叶出现≥2 个 CTL)的患者,记录患者产前、围产期和产后的特征:在701名CTL患者中,74人(10.5%)患有多灶性CTL。8例(12.9%)患者在产前正确识别了CTL多灶性。大多数多发性 CTL 为右侧、单侧多叶病变(33 例,44%)。9例(12.1%)患者发现双侧CTL。CPAM-CPAM 病变是最常见的 CTL 类型(36 例,49%)。3例(4%)患者被确诊为遗传综合征,9例(12.9%)患者存在额外的先天性异常,其中5例存在多种先天性异常。在49例(65%)多肺叶CTL患者中,25例(51%)接受了双肺切除术,24例(49%)接受了保肺手术。住院时间相似。死亡率为5.4%:我们报告了迄今为止最大的多发性 CTL 患者群。结论:我们报告了迄今为止最大的多发性 CTL 患者群。1/10 的 CTL 患者患有多发性 CTL,仅有 12.9% 的患者在产前被发现。可以考虑进行保肺手术。多种额外的先天性异常和遗传综合征可能更为常见,因此应考虑进行基因检测。总体而言,这类患者的预后良好。
{"title":"Neonatal Outcomes of Multiple Congenital Thoracic Lesions.","authors":"Anthony di Natale, Sabrina Flohr, Leny Mathew, Cara Katterman, Colby Gallagher, Thomas A Reynolds, Juliana S Gebb, Howard B Panitch, Edward R Oliver, Natalie E Rintoul, William H Peranteau, Alan W Flake, N Scott Adzick, Holly L Hedrick","doi":"10.1159/000541319","DOIUrl":"10.1159/000541319","url":null,"abstract":"<p><strong>Introduction: </strong>Congenital pulmonary airway malformations (CPAM), intra- and extralobar bronchopulmonary sequestrations (iBPS/eBPS), CPAM-BPS hybrid lesions (HL), congenital lobar emphysema (CLE), bronchial atresia (BA), and foregut duplication cysts (FDC), collectively referred to as congenital thoracic lesions (CTL), are mostly solitary. Patients with multiple CTL are rare, and reports on such cases are scarce. To address this dearth, we analyzed a large multifocal CTL patient cohort.</p><p><strong>Methods: </strong>Retrospective chart review of patients born between September 1, 2013, and March 31, 2023, who underwent surgery for a CTL at our tertiary center. Patients with radiological and surgical diagnosis of multifocal CTL, defined as ≥2 CTL present in more than one lobe were included to record pre-, peri-, and postnatal patient characteristics.</p><p><strong>Results: </strong>Among 701 CTL patients, 74 (10.5%) had multiple CTL. CTL multifocality was prenatally recognized correctly in 8 (12.9%) patients. Most multiple CTL were right-sided, unilateral multilobar lesions (n = 33, 44%). Bilateral CTL were found in 9 (12.1%) patients. CPAM-CPAM lesions were the most prevalent CTL types (n = 36, 49%). Genetic syndromes were confirmed in 3 (4%) and additional congenital anomalies in 9 (12.9%) patients, 5 of those had multiple congenital anomalies. Of 49 (65%) patients with multilobar CTL, 25 (51%) underwent bilobectomy and 24 (49%) lung-sparing surgery. Length of stay was similar. Mortality was 5.4%.</p><p><strong>Conclusion: </strong>We report on the largest patient cohort with multiple CTL to date. Multiple CTL occurred in 1/10 patients with CTL, and only 12.9% were recognized prenatally. Lung-sparing surgery can be considered. Multiple additional congenital anomalies and genetic syndromes may be more common and genetic testing should be considered. Overall, outcomes in this patient population are favorable.</p>","PeriodicalId":12189,"journal":{"name":"Fetal Diagnosis and Therapy","volume":" ","pages":"1-13"},"PeriodicalIF":1.6,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Fetal Diagnosis and Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1